OXFClass II
Mesh, Surgical, Absorbable, Plastic And Reconstructive Surgery
21 CFR 878.3300 / General, Plastic Surgery
OXF is the FDA product code for Mesh, Surgical, Absorbable, Plastic And Reconstructive Surgery, a class II device type, regulated under 21 CFR 878.3300. FDA's definition for this code reads: "For reinforcement of soft tissue where weakness exists in plastic and reconstructive surgery". As of , FDA records hold 8 510(k) clearances under this code, the most recent dated , and no recalls.
Classification record
- Product code
- OXF
- Device name
- Mesh, Surgical, Absorbable, Plastic And Reconstructive Surgery
- FDA definition
- For reinforcement of soft tissue where weakness exists in plastic and reconstructive surgery.
- Regulation
- 21 CFR 878.3300
- Device class
- Class II
- Review panel
- General, Plastic Surgery
- Submission type
- 510(k)
- Implant
- Yes
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- No
- Ingested clearances
- 8
- Ingested recalls
- 0
Clearances, product code OXF
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 2013 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2022 | 1 |
| 2024 | 1 |
| 2025 | 2 |
Applicants with the most clearances
Product code OXF| Applicant | Clearances |
|---|---|
| W. L. Gore & Associates, Inc. | 3 |
| Printbio, Inc. | 2 |
| Acera Surgical, Inc. C/O Linda Braddon, PhD | 1 |
| Allergan | 1 |
| Sofregen Medical, Inc. | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
